Invited Speaker



Update time:2023-12-08 11:38

Dr. Maling Gou is a professor in the State Key Laboratory of Biotherapy, West China Hospital, West China Medical School, Sichuan University, China. His research mainly focuses on bioprinting and biomaterials for biotherapy. He got his PhD from Sichuan University (China) in 2010 and worked as an assistant professor in Sichuan University. He worked as a visiting scholar in UC San Diego since 2012 for 1 year. He was promoted to be a professor in 2017 in Sichuan University. He has developed digital light processing (DLP)-based 3D printing technologies and biomaterials-enabled or -improved therapeutics for potential application in cancer treatment and tissue regeneration. Dr. Gou has published over 100 academic papers in various international journals and has been selected as the associate editor and editorial board member for some international academic journals, such as International Journal of Bioprinting, International Journal of Nanomedicine, Burns & Trauma, Bio-design & Manufacturing. Now, he is the vice-chairman of 3D Printing Technology Branch of the China Medical Biotechnology Association (CMBA), the vice-chairman of Disease Model Technology Branch of the CMBA, and the vice-chairman of Additive Manufacturing Association of Sichuan Province (China).

Topic title: Bioprinting Using a Nanostructured Hydrogel


Three-dimensional (3D) bioprinting provides a rapid tool to customize bionic architectures for various clinically relevant applications, holding the promise of driving significant advancements in medicine. However, the challenge in 3D bioprinting lies in creating high-performance, physiologically relevant products due to the limitation in advanced printing materials. Materials with nanostructure have been found with the ability to elicit unusual biological responses. Therefore, integration of nanostructured materials with 3D bioprinting technology opens new possibilities to meet the physiological requirements for related medical use. In our previous study, we presented a nanostructured hydrogel that can be generated during 3D bioprinting process. By using this hydrogel as printing material, we customized various 3D-bioprinted tissue constructs that effectively promoted the repair and reconstruction of specific defected tissues. Altogether, our work would promote the development and applications of 3D bioprinting technology in medicine.

Congress has ended
Important Dates
Conference Dates
March 29-31, 2024
Deadline for Submission of Abstract

December 31, 2023

Still open for submission

Notification of Abstract Acceptance

January 15, 2024

January 25, 2024